SCHEMBL29519922

SCHEMBL29519922

CC1C=C(Cl)C=CC1(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium SCHEMBL31255853 0.98
SCHEMBL31255840 0.98
Ammonia Solution, Strong SCHEMBL31255848 0.98
Lithium SCHEMBL31255852 0.98
SCHEMBL31255845 0.98
Calcium SCHEMBL31255831 0.96
SCHEMBL3248406 0.77
SCHEMBL27362909 0.76
SCHEMBL6987586 0.74
SCHEMBL4473305 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4611721-A1 STABLE AVIPTADIL FORMULATIONS Relief Therapeutics International SA (CH) 2025-09-10 EP disclosed
WO-2024134383-A1 COMPOSITIONS FOR OPHTHALMOLOGIC DEVICES JOHNSON & JOHNSON VISION CARE, INC. (US) 2024-06-27 WO disclosed
WO-2024134384-A1 COMPOSITIONS FOR OPHTHALMOLOGIC DEVICES JOHNSON & JOHNSON VISION CARE, INC. (US) 2024-06-27 WO disclosed
WO-2024095157-A1 STABLE AVIPTADIL FORMULATIONS RELIEF THERAPEUTICS INTERNATIONAL SA (CH) 2024-05-10 WO disclosed
EP-4210670-A1 COMPOSITIONS FOR PREVENTING INFECTION Altamira Medica, AG (CH) 2023-07-19 EP disclosed
WO-2022053412-A1 COMPOSITIONS FOR PREVENTING INFECTION ALTAMIRA MEDICA, AG (CH) 2022-03-17 WO disclosed